306
Participants
Start Date
March 31, 2007
Primary Completion Date
April 30, 2011
Study Completion Date
August 31, 2011
Lansoprazole
Participants less than 30 kg will receive 15 mg a day, by mouth; participants greater than or equal to 30 kg will receive 30 mg a day, by mouth.
Matching placebo
Participants will receive a placebo pill on a daily basis. To maintain masking, there are two doses of the matching placebo provided to participants depending on participant body weight at randomization: 1.) less than 30kg will receive 15mg po once daily or 2.)greater or equal to 30kg 30mg po once daily.
New York University School of Medicine, New York
New York Medical College, Valhalla
North Shore-Long Island Jewish Health System, New Hyde Park
Penn Presbyterain Medical Center/Penn Lung Center, Philadelphia
Duke University School of Medicine, Durham
Emory University School of Medicine, Atlanta
Nemours Children's Clinic, Jacksonville
University of Miami School of Medicine, Miami
University of South Florida College of Medicine, Tampa
University of Alabama at Birmingham, Birmingham
Davis Heart and Lung Research Institute, Columbus
Indiana University, Indianapolis
University of Minnesota, Minneapolis
Northwestern Memorial Hospital, Chicago
Washington University School of Medicine, St Louis
University of Missouri, Kansas City School of Medicine, Kansas City
Baylor College of Medicine, Houston
National Jewish Medical and Research Center, Denver
University of California San Diego, San Diego
Vermont Lung Center at The University of Vermont, Burlington
American Lung Association Asthma Clinical Research Centers
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Johns Hopkins University
OTHER